Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children - Wikidata - awgldk - TriplyDB

Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children

Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children

http://www.wikidata.org/entity/Q35039955

about

Altered Macrophage and Dendritic Cell Response in Mif-/- Mice Reveals a Role of Mif for Inflammatory-Th1 Response in Type 1 Diabetes The pattern of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over time Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exercise Serum IL-17, IL-23, and TGF-β levels in type 1 and type 2 diabetic patients and age-matched healthy controls α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes.Functional alterations of proinflammatory monocytes by T regulatory cells: implications for the prevention and reversal of type 1 diabetes.Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis.Transcriptional signatures as a disease-specific and predictive inflammatory biomarker for type 1 diabetes Inhibition of increased circulating Tfh cell by anti-CD20 monoclonal antibody in patients with type 1 diabetes.Use of transcriptional signatures induced in lymphoid and myeloid cell lines as an inflammatory biomarker in Type 1 diabetes Lutein dietary supplementation attenuates streptozotocin-induced testicular damage and oxidative stress in diabetic rats Non-cell autonomous influence of the astrocyte system xc- on hypoglycaemic neuronal cell death.Identification of a serum-induced transcriptional signature associated with type 1 diabetes in the BioBreeding rat.Th17 cells in human disease.Increased Blood Levels of Growth Factors, Proinflammatory Cytokines, and Th17 Cytokines in Patients with Newly Diagnosed Type 1 Diabetes.Innate inflammation in type 1 diabetes Dysregulated Toll-like receptor-induced interleukin-1β and interleukin-6 responses in subjects at risk for the development of type 1 diabetes Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY).Offloading treatment is linked to activation of proinflammatory cytokines and start of bone repair and remodeling in Charcot arthropathy patients.Blood-based signatures in type 1 diabetes.The serum IL-6 profile and Treg/Th17 peripheral cell populations in patients with type 1 diabetes.Subclinical Inflammation and Endothelial Dysfunction in Patients with Chronic Pancreatitis and Newly Diagnosed Pancreatic Cancer.Blocking type I interferon signaling rescues lymphocytes from oxidative stress, exhaustion, and apoptosis in a streptozotocin-induced mouse model of type I diabetes.Interleukin-1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset.Polymorphic variant at the IL2 region is associated with type 1 diabetes and may affect serum levels of interleukin-2.Interleukin-1 stimulates catabolism in C2C12 myotubes.Increased circulating IL-8 is associated with reduced IGF-1 and related to poor metabolic control in adolescents with type 1 diabetes mellitus.Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells.The role of MIF in type 1 and type 2 diabetes mellitus.Alpha-lipoic acid improves subclinical left ventricular dysfunction in asymptomatic patients with type 1 diabetes.Toll-like receptors, the NLRP3 inflammasome, and interleukin-1β in the development and progression of type 1 diabetes.Gevokizumab in type 1 diabetes mellitus: extreme remedies for extreme diseases?Understanding Disease-Drug Interactions in Cancer Patients: Implications for Dosing Within the Therapeutic Window.Interleukin-1β (IL-1β) transcriptionally activates hepcidin by inducing CCAAT enhancer-binding protein δ (C/EBPδ) expression in hepatocytes.Skeletal growth and bone mineral acquisition in type 1 diabetic children; abnormalities of the GH/IGF-1 axis.Pancreatic islet inflammation: an emerging role for chemokines.Comparative and correlative assessments of cytokine, complement and antibody patterns in paediatric type 1 diabetes.Imbalanced Macrophage and Dendritic Cell Activations in Response to Candida albicans in a Murine Model of Diabetes Mellitus.Association between IgE-mediated allergies and diabetes mellitus type 1 in children and adolescents.Glucagon-like peptide-1 receptor agonist exendin-4 protects against interleukin-1β-mediated inhibition of glucose-stimulated insulin secretion by mouse insulinoma β cells.

P2860

Q27349718-D717A3E7-FB2A-46A3-A848-1F208FE070E6 Q28285897-B55B19C7-936D-4DD9-8D3D-F5EF98F205D0 Q28566793-775B98FF-E70D-4686-BDCE-E5BF1F6E8354 Q33786938-87D70E38-17E6-4102-9574-716A15A22C0B Q33999020-81409E19-44C3-4F8C-A8AF-D6EC0C18B082 Q34072307-D95FE293-B183-4639-BF9B-483AD94EA2B1 Q34666831-418D21A0-792D-40BD-B8C7-1B9088A6961A Q34693197-0E4D5B04-A313-4FDC-8159-9608CAD1F631 Q35053311-7A762786-DCA2-4E27-810E-61FFD0A9DBE1 Q35062538-9F21ED5D-73C6-4062-BC99-15F4D50F4589 Q35677591-DF4535FA-7777-48B2-8C6E-5E853586F2D4 Q35744426-7D715200-6F10-4636-91F2-BD0D7DF31CD1 Q35757080-85A2E176-C01A-465A-BAC4-66D62FB05955 Q35820734-AFB02816-FF3E-462D-A999-D148524E8907 Q35860851-1634C2C3-47C9-415A-9E8A-F16667A6D06F Q36225939-566E5128-9DA3-423C-A742-8CB75A20D7CD Q36249702-CED63EAD-8EB3-4DA8-B773-1B4529FE2960 Q36335960-701140E9-FF9A-41A1-A722-8DCFCF278BD4 Q36364298-23C81C98-5113-4B10-89B6-0640764EF072 Q36552481-B480E25F-C68B-4549-96AA-0E2588871253 Q36679011-2A957BF5-06B4-4266-9CEE-3C3EDD6439FB Q36680316-6A053EF6-5700-412B-A080-65422F77D0BA Q36711831-B7C18BE3-459D-430A-9B16-8BDDA5FDF67D Q36788764-83E29601-3AD8-40AF-A811-D0E36A00CA0E Q37330708-E1AD0EB5-2BE3-4563-A449-EE702D9E9539 Q37338915-362FDEE2-8051-4ECD-8616-ECF4EA29F511 Q37399738-05BE5600-58F2-42D4-BEF7-89A9CBFD6290 Q37405753-5A271228-F6E9-4185-A156-B649540DCFE9 Q37542812-DCB5C9FB-C1F2-4F2E-A78C-EE236CB78CBB Q37598215-13B23337-4C89-4BE2-88F8-C6FB30675FE6 Q37984231-D3CBA495-4EBA-48DD-892E-8CD35900A642 Q38235580-5E8BC197-8604-4755-A93B-18D26A8AC938 Q38390695-381E6943-1E3F-4D6F-8243-80CADF3AC72F Q38706264-CCB5CA12-6ACE-433E-8B4C-A3EEDFAE9467 Q38797855-38505236-3101-41A0-BB9D-97FF5A9C6BD1 Q39249398-3BA882AB-CF18-4E4B-94F7-E18734485C81 Q40162151-9F8F3CEB-619F-4661-BF03-745FA2EFA55B Q40703127-9C821539-0D00-44E7-A9D2-ADE6D2041825 Q41572131-35FD0219-CC55-4EDA-B4A7-B3ACFBE82A80 Q41692104-10917EB9-764C-4CFA-86E1-813EB11EF9A4

P2860

Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children

http://www.wikidata.org/entity/Q35039955

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children

@ast

Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children

@en

type

label

Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children

@ast

Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children

@en

prefLabel

Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children

@ast

Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children

@en

P1433

Q35039955-1E2A912D-0E25-4631-8ACA-2AD5B7032A7F

P1476

Q35039955-2451CD26-77E1-406B-8EA3-CFCD0C122FB7

P2093

Q35039955-0A20046E-C48D-4BCA-BF5E-47C0F7890EC0

Q35039955-515AC5B6-F9AE-4729-81E1-3F8B43425F92

Q35039955-68A605C0-9C71-44E8-B0CE-7966457B6FF6

Q35039955-9CD81C71-DA5F-4F45-BC8F-B0DF65434284

Q35039955-DB4DA5C2-6E0E-408C-B856-986930F94B58

P2860

Q35039955-02025F1E-9D44-4CBC-A563-C2527A2C8CC3

Q35039955-0C659E74-F3F1-4F8E-A82B-9F4984AF3319

Q35039955-25DA04C5-2F0D-4D4C-90BF-94179A6F8913

Q35039955-336CF910-C9E7-49EE-88E1-99A794D91C29

Q35039955-3B288525-4DD3-4163-8A8D-8BD4FF28A7D3

Q35039955-5527B546-C44D-4845-85A6-E5398DB93F94

Q35039955-60BED190-874A-4299-9287-7B5711AE42EA

Q35039955-7339348D-C7DD-40A4-B680-923B674E0489

Q35039955-8C5E27C4-B156-4075-8D10-9F0B13841791

Q35039955-9157755B-50EE-4808-BC1A-D1057429183A

P304

Q35039955-D7CA6960-F2F4-466D-A701-F064EE19DE93

P31

Q35039955-3476B658-5A4C-4A2D-ACCB-DA54ABF711C0

P356

Q35039955-4856184D-1F5E-48A5-B48F-8B37A09E3C21

P433

Q35039955-E83463A2-B198-4D57-AC79-2D34388A2170

P478

Q35039955-0C3BC3D9-AD8F-405B-B904-079FBE7EBF11

P577

Q35039955-4967DD77-694A-458E-85F0-3FAD01E77691

P698

Q35039955-6CD6E3B3-B0BD-4258-A680-0546590B2BA2

P921

Q35039955-94BF9AA5-6DA1-472F-8F6F-60E852E4CC8F

P932

Q35039955-EF12B2F4-C829-4B7D-B47B-A7E32D541F72

P356

P1433

Mediators of Inflammation

P1476

Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children

@en

P2093

Bilal Ustundag

http://www.w3.org/2001/XMLSchema#string

Erdal Yilmaz

http://www.w3.org/2001/XMLSchema#string

Metin Kaya Gurgoze

http://www.w3.org/2001/XMLSchema#string

Saadet Akarsu

http://www.w3.org/2001/XMLSchema#string

Yasar Dogan

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple immuno-regulatory defects in type-1 diabetes

Cytokines suppress human islet function irrespective of their effects on nitric oxide generation.

Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats.

TNF-alpha and insulin resistance: summary and future prospects.

RAGE: a novel cellular receptor for advanced glycation end products.

Alterations of in vitro interleukin 1 and 2 in diabetic children.

Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes.

Mediators of inflammation in children with type I diabetes mellitus: cytokines in type I diabetic children.

Cytokine secretion is impaired in women with diabetes mellitus.

Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration.

P304

59206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/MI/2006/59206

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2006

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16864906

http://www.w3.org/2001/XMLSchema#string

P921

P932

1570393

http://www.w3.org/2001/XMLSchema#string